Eunomia Pharma Services provides outsourced promotional and medical materials review, copy approval process support and review operations for pharmaceutical companies in the UK and Europe. We work within your SOPs and systems, connecting specialist reviewers, local expertise, approval workflows and traceable records. The scope, markets and any final signatory arrangements are agreed before work begins.
Discuss this service
UK and European pharmaceutical teams
Commercial, medical and compliance teams that need additional materials-review capacity, a defined outsourced review service or a more consistent process across markets. We agree the material types, products, audiences, channels and country requirements with you.
A lean team can struggle with increasing material volumes, incomplete submissions and repeated review cycles. Eunomia combines people and process support so reviewers, material owners and approvers understand the evidence and decisions each stage needs.
Support can cover a defined process or market, supplement your team or form part of an ongoing shared compliance service. Capacity, reviewer suitability, service levels and system access are agreed for the engagement.
Published client evidence
Our published August 2026 case study describes support for a UK-headquartered pharmaceutical company expanding in Europe. The engagement combined experienced reviewers and signatories, workflows, SOPs, templates and reporting.
It reports turnaround reducing from five days to two and review cycles from four to two. These results relate to that engagement and do not guarantee the same outcome for other clients.
Read the materials-review case studyWhat we can take on
What this gives you
Defined review capacity without building an equivalent permanent function
Clear ownership of review, escalation, certification and release
Visible workload, review feedback and evidence for oversight
Compliance review, medical review, internal approval and final certification are distinct decisions. For UK promotional material, the ABPI Code sets requirements for certification of the final form by an eligible nominated signatory. Outsourcing a review task does not itself confer certification authority.
Any signatory support must be separately agreed, including eligibility, product knowledge, experience and nomination requirements. Your company retains oversight of the process and its responsibilities under the applicable rules.
Official reference: PMCPA Clause 8 — Certification and Examination
European support needs to account for the EFPIA Code alongside applicable national codes and laws. A UK review or certificate should not be assumed to satisfy another market’s requirements. We agree the markets, local expertise and decision routes within the scope.
Official reference: EFPIA Code
Sources checked 19 October 2026. Confirm the current requirements for the material and intended use.
Share the countries and products in scope, material types and audiences, expected volumes, current SOPs, review systems and signatory arrangements. This helps us propose the right people, workflow and service levels.
Questions, answered
Yes. Eunomia provides promotional and medical materials review and copy approval process support, including specialist reviewers, workflows, SOPs, templates, records and reporting. The exact roles, capacity and markets are agreed for each engagement.
The service can support UK review under the ABPI Code and coordination of European review with relevant local expertise. Applicable national requirements, products and reviewer suitability must be confirmed when scoping the service.
Not automatically. Review and final certification are distinct. Any nominated signatory role must be separately agreed and meet the applicable qualifications, knowledge, experience and nomination requirements. An ordinary reviewer approval does not replace certification.
Yes. The service is designed around your SOPs and systems, with access, training, roles and evidence requirements agreed during setup. Specific platform requirements should be confirmed at scoping.
Automation can support submission checks, routing, version control and reporting. It does not replace accountable human review or the eligible nominated signatory’s required certification decision.
The published materials-review shared-service case study describes support for a UK-headquartered pharmaceutical company expanding across Europe, combining reviewers, signatories, workflows, SOPs and operational reporting. Its results are specific to that engagement.
We will listen, ask a few questions and recommend the right scope—without obligation or pressure.
Start a conversation